IRIS
TERRANOVA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.210
NA - Nord America 1.159
EU - Europa 449
SA - Sud America 243
AF - Africa 25
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.094
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.213
US - Stati Uniti d'America 1.086
CN - Cina 473
HK - Hong Kong 316
BR - Brasile 181
IT - Italia 134
VN - Vietnam 117
GB - Regno Unito 110
DE - Germania 70
CA - Canada 42
AR - Argentina 27
MX - Messico 21
IN - India 20
NL - Olanda 20
FR - Francia 19
CZ - Repubblica Ceca 18
JP - Giappone 16
ZA - Sudafrica 11
TR - Turchia 10
CL - Cile 9
EE - Estonia 9
FI - Finlandia 9
BD - Bangladesh 8
ES - Italia 8
ID - Indonesia 8
PL - Polonia 7
RU - Federazione Russa 7
SE - Svezia 7
AU - Australia 6
EC - Ecuador 6
UY - Uruguay 5
AT - Austria 4
CO - Colombia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IQ - Iraq 4
TW - Taiwan 4
UA - Ucraina 4
KR - Corea 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CU - Cuba 1
DZ - Algeria 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.094
Salva come PNG Salva come JPEG
Città #
Singapore 386
Ashburn 315
Hong Kong 308
Hefei 212
Boardman 116
Beijing 87
London 86
San Jose 86
Shanghai 68
Rome 67
Santa Clara 66
Ho Chi Minh City 41
Los Angeles 37
San Francisco 35
Munich 33
Dallas 27
São Paulo 24
Washington 21
Buffalo 20
Montreal 20
Brno 18
Council Bluffs 18
Hanoi 16
Toronto 16
Amsterdam 14
Tokyo 14
Seattle 13
Secaucus 12
Brooklyn 10
Chicago 10
New York 10
Pune 10
Grumo Nevano 9
Johannesburg 9
Boston 8
Milan 8
Paris 8
Rio de Janeiro 8
Da Nang 7
Mexico City 7
Coral Springs 6
Haiphong 6
Warsaw 6
Naples 5
Phoenix 5
Santiago 5
Stockholm 5
Temecula 5
Thái Bình 5
Biên Hòa 4
Buenos Aires 4
Canberra 4
Catania 4
Cuautitlán Izcalli 4
Helsinki 4
Ninh Bình 4
Taipei 4
The Dalles 4
Turku 4
Ankara 3
Anápolis 3
Charlotte 3
Cleveland 3
Cusano Milanino 3
Duque de Caxias 3
Guangzhou 3
Guayaquil 3
Hyderabad 3
Hải Dương 3
Las Vegas 3
Lima 3
Louisville 3
Manaus 3
Medellín 3
Montevideo 3
Mysore 3
Newark 3
Nuremberg 3
Quận Bình Thạnh 3
Ribeirão Preto 3
Salvador 3
Seoul 3
Sonoma 3
Vĩnh Tường 3
Zhengzhou 3
Alexandria 2
Baghdad 2
Banhā 2
Belo Horizonte 2
Belém 2
Brasília 2
Brusaporto 2
Buford 2
Calgary 2
Cape Town 2
Chennai 2
Columbia 2
Cotia 2
Del Viso 2
Dhaka 2
Totale 2.476
Salva come PNG Salva come JPEG
Nome #
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 225
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 219
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 217
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 217
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 212
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 212
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 211
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 206
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 205
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 203
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 202
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 200
Human embryo: what about relatedness? 198
Does HE4 have a role in the recurrence of ovarian cancer? 191
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 190
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 190
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 188
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 186
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 177
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 173
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 170
A critical review on HE4 performance in endometrial cancer: where are we now? 116
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 114
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 107
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 107
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 102
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 98
A new type of absorbable barbed suture for use in laparoscopic myomectomy 98
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 97
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 96
Assessing HPV vaccination perceptions with online social media in Italy 96
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 96
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 96
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 95
[The role of laparoscopy in ovarian carcinoma]. 93
Chirurgia Benigna 92
Economic impact among family caregivers of patients with advanced ovarian cancer 92
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 90
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 87
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 86
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 53
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 51
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 47
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 47
Miomectomia laparoscopica: fattibilità e learning curve 46
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 45
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 43
Studio prospettico randomizzato comparativo tra due tecniche 42
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 42
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 41
The role of ovarian fossa evaluation in patients with ovarian endometriosis 41
Laparoscopic myomectomy learning curve safety and feasibility. 41
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 40
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 40
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 39
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 38
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 37
Ovarian cancer relapse: From the latest scientific evidence to the best practice 37
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 37
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 37
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 37
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 33
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 33
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 33
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 32
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 31
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 31
Ten years of HPV vaccines: State of art and controversies 31
Real-time infrared thermography for ureter detection during hysterectomy 31
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 30
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 30
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 29
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women 29
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 29
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 29
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 29
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 29
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 28
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 28
The role of macroplastique implantation in the management of occult urinary stress incontinence 28
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 28
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 27
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 27
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 27
Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues 26
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 25
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix 25
Hormone replacement therapy in cancer survivors: Utopia? 25
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 25
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 25
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 25
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 24
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 24
The Role of Novel Serum Biomarker HE4 in Endometrial Cancer 24
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 24
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 24
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 23
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 23
REM (RISK OF ENDOMETRIAL MALIGNANCY): A PROPOSAL FOR A NEW SCORING SYSTEM TO EVALUATE RISK OF ENDOMETRIAL MALIGNANCY 22
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 22
Totale 7.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.876 107 25 122 33 27 98 83 65 276 341 2.288 2.411
2025/20261.588 313 168 182 399 202 225 99 0 0 0 0 0
Totale 8.144